Nervous About Spending? Stocks in Three Tech Giants
The AI spending spree has some investors on edge. This guide explains why three big tech leaders may weather the stor...
Which Sp 500 Fund Grew Most In 2024 Retirement
This piece examines Which Sp 500 Fund Grew Most In 2024 Retirement, focusing on growth drivers, expense ratios, and suitability for retirement accounts.
25,898 articles
Think Bull Market Just Getting Started? ETFs Lead Next Leg
Three ETFs are positioning investors for the next leg of AI-driven growth, offering diversified exposure as markets r...
Core Scientific Stock Year Signals Pivot Data Center Growth
A large new stake underscores Core Scientific's shift toward data center services. This article breaks down the impli...
Under Greg Abel, Apple and Alphabet Berkshire Portfolio
Berkshire Hathaway is changing under Greg Abel, shifting toward concentrated bets on Apple and Alphabet. This article...
Dividend ETFs with Over 6% Yields Stand Out in 2026
As the market keeps rates elevated, three dividend ETFs with over 6% yields offer straightforward income without upsi...
Crypto Investor Charged with $20M Fraud Tied to Eight Firms
A Sioux Falls crypto investor faces 29 federal counts in a scheme prosecutors say used eight entities and new investo...
Time on His Side: Michael Dell Remains the Real Icon
Carl Icahn steps back from the activist spotlight as Michael Dell solidifies a long-term playbook for Dell Technologi...
Solana ETFs Build ‘Serious’ Investor Base Outpacing Bitcoin
Solana ETFs have drawn substantial institutional money despite a steep SOL price decline, signaling a shift in convic...
Weak Jobs Data Rising: Why Investors Face a Harder Market
A rare mix of weak jobs data rising and rising oil prices is reshaping market readings. This guide explains what it m...
Goldman Sachs Engineered QYLD Rival Delivers 10% Yield
Goldman Sachs-backed GPIQ is carving out a niche as a high-yield Nasdaq-100 income vehicle. The fund uses a laddered ...
ClearPoint Neuro (CLPT) Earnings Outlook for Investors
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
Lemonade After Morgan Stanley's Upgrade: Is It a Buy?
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status